Pentoxifylline
- Product NDC
- 43353-123
- 11-digit product format
- 433530123
- Labeler code
- 43353
- Product ID
- 43353-123_3b7207cf-7691-4367-bf58-7d0eb6a984e4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pentoxifylline
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA075028
- Marketing category
- ANDA
- Marketing start
- 2014-08-22
- Marketing end
- 0000-00-00
- Substance
- PENTOXIFYLLINE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43353-123-92 | Pentoxifylline | 270 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 270 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-123 | PENTOXIFYLLINE TABLET, EXTENDED RELEASE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 2 | Legacy NDC, 1 package rows | 20191219_e95e105c-d2b0-47f8-9c9c-c825d5d85578.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-123-92 | 43353012392 | 270 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-123-92) | 2015-11-10 | 0000-00-00 | No | No | Current |